Form 4: Penumbra Inc. CEO Adam Elsesser Executes Stock Option and Sells Shares Under 10b5-1 Plan

CEO Adam Elsesser exercised stock options and sold shares of Penumbra Inc. common stock on March 19, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 19, 2025, Adam Elsesser, CEO and President of Penumbra Inc., executed a stock option and sold shares of common stock.
• The transactions were carried out under a Rule 10b5-1 trading plan.
• Elsesser exercised an option to acquire 27,976 shares at $30 per share.
• He then sold a total of 15,520 shares in multiple transactions at prices ranging from $271.07 to $278.89.
• Following these transactions, Elsesser directly owns 27,752 shares of common stock and indirectly owns 837,582 shares through a trust.
• He also directly owns 349,048 derivative securities (stock options).

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing reflects routine transactions under a pre-arranged trading plan. No indication of positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to use Rule 10b5-1 plans to manage their stock holdings and avoid accusations of insider trading. The market will likely interpret this as a standard transaction unless the volume or timing is unusual.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a significant component.
• Rule 10b5-1 trading plans are a common tool used by executives at publicly traded companies like Penumbra, Medtronic, and Boston Scientific to manage their stock sales in a compliant manner.
• The reported transactions are typical for executives managing their personal finances and diversifying their assets.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The impact on employees, customers, suppliers, and creditors is expected to be negligible.

Key Dates

Keywords

Form 4, Penumbra Inc, Adam Elsesser, Stock Options, Rule 10b5-1, Insider Trading, Share Sales, Beneficial Ownership